Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
78.73-2.03 (-2.51%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close80.76
Bid0.00 x
Ask0.00 x
Day's Range77.92 - 80.39
52wk Range75.90 - 134.71
1y Target EstN/A
Market Cap19.51B
P/E Ratio (ttm)-69.43
Avg Vol (3m)1,414,667
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • American City Business Journals10 hours ago

    Here's the big news we're likely to hear when Vertex, Biogen report Q3 this week

    Earnings season for our Massachusetts biotech giants kicks off this week when Vertex Pharmaceuticals reports its third quarter financials on Tuesday evening, followed by Biogen on Wednesday morning. While probably just a fluke, it’s unusual for Vertex (VRTX) to be the first local biotech to give a quarterly update, as that honor usually goes to Biogen (BIIB). Vertex : To some extent, the financial news expected from the Boston-based company is already old news.

  • Benzinga17 hours ago

    Vertex Pharmaceuticals Relapses To A Neutral Rating At H.C. Wainwright

    H.C. Wainwright & Co. downgraded shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) from Buy to a Neutral rating citing that fundamentals are not holding up. The firm also slashed its target ...

  • Drug Stocks Q3 Earnings Roster for Oct 25: MRK, LLY & More
    Zacks17 hours ago

    Drug Stocks Q3 Earnings Roster for Oct 25: MRK, LLY & More

    Four more companies from the healthcare sector are set to report their third-quarter results on Oct 25.